{"id":28965,"date":"2014-08-20T10:50:12","date_gmt":"2014-08-20T14:50:12","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=28965"},"modified":"2014-08-20T10:50:12","modified_gmt":"2014-08-20T14:50:12","slug":"yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965","title":{"rendered":"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 08\/20\/2014 (wallstreetpr) \u2013<strong> Alcobra Ltd (NASDAQ:ADHD)<\/strong>, an emerging drugs company with more than $296 million in market cap, announced first successful enrollment of a patient for its <a href=\"http:\/\/www.streetinsider.com\/Corporate+News\/Alcobra+Ltd.+%28ADHD%29+Enrolls+First+Patient+in+MDX+Phase+IIb+for+Fragile+X+Syndrome\/9765845.html\" target=\"_blank\">Phase IIb<\/a> study of its drug candidate MDX for the Fragile X Syndrome.<\/p>\n<p style=\"text-align: justify;\"><strong>Patient enrollment<\/strong><\/p>\n<p style=\"text-align: justify;\">The company intends to enroll 60 patients in the category of adolescents and adults for the 6 week study. The drug will be tried against a placebo. It targets 11 clinical sites, mostly in the U.S. for the trial of the experimental drug. According to CEO Yaron Daniely, their interest in the study is to hit end point targets, which is data that suggest a potential benefit for the Fragile X patients.<\/p>\n<p style=\"text-align: justify;\">Alcobra Ltd (NASDAQ:ADHD) expects to complete the patients enrollment exercise and be able to report top-line data in 4Q2014, if all goes are planned.<\/p>\n<p style=\"text-align: justify;\">Shares of Alcobra are up almost 15% this year but tumbled nearly 5% in the last session to end the day down at $20.67.<\/p>\n<p style=\"text-align: justify;\"><strong>Financial performance<\/strong><\/p>\n<p style=\"text-align: justify;\">The company reported its most recent earnings on Aug. 11, during which it said it suffered a loss of $0.57 a share, but managed to live up to Wall Street expectation, which was a loss of $0.57 a share. The most recent quarter was characterized by higher operating expenses, which rose to $6.9 million compared with $6.5 million in 1Q2014 and $0.5 million in the like quarter last year. It said total expenses in the latest quarter were $7.8 million, which compared unfavorably with total expenses of $1.2 million in 2Q2013. However, total expenses remained flat on a quarter-to-quarter basis.<\/p>\n<p style=\"text-align: justify;\">Alcobra Ltd (NASDAQ:ADHD) is mostly focused on the development of new treatments, especially for patients with cognitive disorders. Its current study areas include treatments for Fragile X Syndrome and Attention Deficient Hyperactivity Disorder (ADHD).<\/p>\n<p style=\"text-align: justify;\">Analysts on the average recommend the stock of Alcobra Ltd (NASDAQ:ADHD) as a &#8220;buy&#8221;, and they have a target price of almost $34.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 08\/20\/2014 (wallstreetpr) \u2013 Alcobra Ltd (NASDAQ:ADHD), an emerging drugs company with more than $296 million in market cap, announced first successful enrollment of [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":28966,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[8172,4366,4367],"stock_ticker":[],"class_list":["post-28965","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-alcobra-ltd","tag-alcobra-ltd-nasdaqadhd","tag-nasdaqadhd","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient  - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient  - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 08\/20\/2014 (wallstreetpr) \u2013 Alcobra Ltd (NASDAQ:ADHD), an emerging drugs company with more than $296 million in market cap, announced first successful enrollment of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-08-20T14:50:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"260\" \/>\n\t<meta property=\"og:image:height\" content=\"120\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Greg Folin\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Greg Folin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\"},\"author\":{\"name\":\"Greg Folin\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\"},\"headline\":\"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient\",\"datePublished\":\"2014-08-20T14:50:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\"},\"wordCount\":324,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg\",\"keywords\":[\"Alcobra Ltd\",\"Alcobra Ltd (NASDAQ:ADHD)\",\"NASDAQ:ADHD\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\",\"name\":\"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg\",\"datePublished\":\"2014-08-20T14:50:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg\",\"width\":260,\"height\":120},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e\",\"name\":\"Greg Folin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg\",\"caption\":\"Greg Folin\"},\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient  - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965","og_locale":"en_US","og_type":"article","og_title":"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient  - Wall Street PR","og_description":"Boston, MA 08\/20\/2014 (wallstreetpr) \u2013 Alcobra Ltd (NASDAQ:ADHD), an emerging drugs company with more than $296 million in market cap, announced first successful enrollment of [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-08-20T14:50:12+00:00","og_image":[{"width":260,"height":120,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg","type":"image\/jpeg"}],"author":"Greg Folin","twitter_misc":{"Written by":"Greg Folin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965"},"author":{"name":"Greg Folin","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e"},"headline":"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient","datePublished":"2014-08-20T14:50:12+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965"},"wordCount":324,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg","keywords":["Alcobra Ltd","Alcobra Ltd (NASDAQ:ADHD)","NASDAQ:ADHD"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965","url":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965","name":"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg","datePublished":"2014-08-20T14:50:12+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/08\/alcobra_by_org_260.jpg","width":260,"height":120},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/yaron-daniely-hopes-for-the-best-as-alcobra-ltd-nasdaqadhd-enrolls-first-patient-28965#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Yaron Daniely Hopes For The Best As Alcobra Ltd (NASDAQ:ADHD) Enrolls First Patient"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/09a8586a8976289812879bbc81ac988e","name":"Greg Folin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2020\/05\/4w1JQvu5_400x400-300x300.jpg","caption":"Greg Folin"},"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/greg-folin"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28965","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=28965"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/28965\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/28966"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=28965"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=28965"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=28965"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=28965"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}